Invention Grant
US09388122B2 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor 有权
放射性酪氨酸衍生物,其制备方法,正电子成像用标记剂和用于评价分别由放射性酪氨酸衍生物构成的肿瘤恶性程度的药剂和检测肿瘤的方法

  • Patent Title: Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor
  • Patent Title (中): 放射性酪氨酸衍生物,其制备方法,正电子成像用标记剂和用于评价分别由放射性酪氨酸衍生物构成的肿瘤恶性程度的药剂和检测肿瘤的方法
  • Application No.: US11597557
    Application Date: 2005-05-25
  • Publication No.: US09388122B2
    Publication Date: 2016-07-12
  • Inventor: Kengo SatoHideo Tsukada
  • Applicant: Kengo SatoHideo Tsukada
  • Applicant Address: JP Hamamatsu-shi, Shizuoka
  • Assignee: HAMAMATSU PHOTONICS K.K.
  • Current Assignee: HAMAMATSU PHOTONICS K.K.
  • Current Assignee Address: JP Hamamatsu-shi, Shizuoka
  • Agency: Drinker Biddle & Reath LLP
  • Priority: JPP2004-159941 20040528
  • International Application: PCT/JP2005/009530 WO 20050525
  • International Announcement: WO2005/115971 WO 20051208
  • Main IPC: C07C229/36
  • IPC: C07C229/36 A61K51/04 C07B59/00
Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor
Abstract:
It is intended to provide a radioactive tyrosine derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein R1 represents a group selected from the group consisting of —11CH3, —11CH2CH3, —CH218F, and —CH2CH2CH218F.
Information query
Patent Agency Ranking
0/0